[1]
“Non-osteoporotic Loss of Spinal Bone. Denosumab as a Therapeutic Tool and its Implications”, Rev. Asoc. Arg. Ort. y Traumatol, vol. 89, no. 1, pp. 83–89, Feb. 2024, doi: 10.15417/issn.1852-7434.2024.89.1.1802.